Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-02-27FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Eywa Pharma Inc)
FDA approves Eywa Pharma Inc's supplemental application for methylphenidate hydrochloride, a generic ADHD medication, under an ANDA.
-
FDA approval · 2024-02-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' combination amphetamine salts product (dextroamphetamine saccharate, a…
-
FDA approval · 2024-02-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application from Granules Pharmaceuticals Inc. for a generic product containing four amphetamine/dextroamphetami…
-
FDA approval · 2024-02-27FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Sun Pharmaceutical Industries, Inc. under the ANDA framewo…
-
FDA approval · 2024-02-20FDA Approved: GUANFACINE EXTENDED-RELEASE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for guanfacine extended-release from Apotex Corp., enabling the generic product's approval.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment [Phase 3]
A Phase 3 clinical trial evaluating treatment for impulsive aggression in adolescents with ADHD, terminated with results posted in 2024.
-
FDA approval · 2024-02-14FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) from Lannett Company, Inc., enabling a new generic pro…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD [Phase 3]
Open-label long-term safety and efficacy study of viloxazine ER (SPN-812) in adults with ADHD completed; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Effectiveness of the Serious Video Game MOON in Emotional Regulation in ADHD [Phase 3]
Phase 3 clinical trial update on MOON, a serious video game, for emotional regulation in ADHD. The study has completed.
-
FDA approval · 2024-02-12FDA Approved: ATOMOXETINE — Supplemental Application (Northstar Rx LLC)
FDA approves a supplemental application for atomoxetine from Northstar Rx LLC under ANDA 079019, enabling a generic version of the ADHD medi…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism [Phase 4]
Phase 4 trial evaluating lisdexamfetamine for safety and effect in children with ADHD and autism spectrum disorder has completed.
-
FDA approval · 2024-02-08FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Granules Pharmaceuticals Inc. Dexmethylphenidate hydrochlo…
-
FDA approval · 2024-02-07FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Mayne Pharma Commercial LLC)
FDA approved a supplemental application for methamphetamine hydrochloride (Mayne Pharma Commercial LLC).
-
FDA approval · 2024-02-02FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original ANDA for lisdexamfetamine dimesylate (Novadoz Pharmaceuticals LLC), a generic version of the stimulant used to trea…
-
FDA approval · 2024-01-30FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for lisdexamfetamine dimesylate by Apotex Corp., approving a generic product under the supplemental …
-
FDA approval · 2024-01-26FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
FDA approved NorthStar RxLLC's supplemental application for a generic four-salt amphetamine/dextroamphetamine product (dextroamphetamine sac…
-
FDA approval · 2024-01-26FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Oryza Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic product containing four amphetamine salts (dextroamphetamine saccharate, amphetamine a…
-
FDA label_change · 2024-01-17FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lisdexamfetamine dimesylate from Hikma Pharmaceuticals USA Inc., resulting in changes to the pro…
-
FDA approval · 2024-01-16FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for amphetamine sulfate manufactured by Aurolife Pharma, LLC.
-
FDA approval · 2024-01-11FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from Trigen Laboratories, LLC.
-
FDA approval · 2024-01-05FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for lisdexamfetamine dimesylate, a generic version of the ADHD medication.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD [Phase 4]
Phase 4 trial update on efficacy of Concerta for treating adult ADHD in mothers of children with ADHD (completed).
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD [Phase 2]
Phase 2 trial evaluating safety and efficacy of a d-amphetamine transdermal system versus placebo in children and adolescents with ADHD has …
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: The Effects of a Single Dose of Methylphenidate on Motor Performance [Phase 4]
Phase 4 clinical trial investigating the effects of a single dose of methylphenidate on motor performance in ADHD.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD [Phase 4]
Phase 4 trial update evaluating omega-3 fatty acids as adjunctive therapy for stimulants in children with ADHD.